Literature DB >> 10381811

Identification of selective mechanism-based inactivators of cytochromes P-450 2B4 and 2B5, and determination of the molecular basis for differential susceptibility.

S M Strobel1, G D Szklarz, Y He, M Foroozesh, W L Alworth, E S Roberts, P F Hollenberg, J R Halpert.   

Abstract

Rabbit cytochromes P-450 (P-450) 2B4 and 2B5 differ by only 12 amino acid residues yet they exhibit unique steroid hydroxylation profiles. Previous studies have led to the identification of active site residues that are determinants of these specificities. In this study, mechanism-based inactivators were identified that discriminate between the closely related 2B4 and 2B5 enzymes. A previously characterized inhibitor, 2-ethynylnaphthalene (2EN), was found to be selective for 2B4 inactivation. As inhibitor metabolism and the partition ratio affect susceptibility, molecular dynamics simulations were performed to assess the stability of the productive binding orientation of 2EN within 2B4 and 2B5 three-dimensional models. Although 2EN was stable within the 2B4 model, it exhibited substantial movement away from the heme moiety in the 2B5 model. However, heterologously expressed 2B5 was found to catalyze the oxidation of 2EN to the stable product 2-naphthylacetic acid. Thus, the increased mobility of 2EN may result in reduced susceptibility of 2B5 by increasing the probability that the reactive ketene intermediate hydrolyzes with water instead of reacting with active site residues. Another compound, 1-adamantyl propargyl ether (1APE), selectively inactivated 2B5. The structural basis for 2EN and 1APE susceptibility was assessed using active site mutants. Interconversion of 2EN susceptibility was observed for 2B4 or 2B5 mutants containing a single alteration at residue 363. Single substitutions in 2B4 also conferred susceptibility to 1APE; however, multiple alterations were required to reduce the susceptibility of 2B5. These alterations may influence inhibitor susceptibility by affecting the stability of the productive binding orientation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10381811

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  13 in total

1.  QSAR models of cytochrome P450 enzyme 1A2 inhibitors using CoMFA, CoMSIA and HQSAR.

Authors:  J Sridhar; M Foroozesh; C L Klein Stevens
Journal:  SAR QSAR Environ Res       Date:  2011-10-17       Impact factor: 3.000

2.  Ethynyl and Propynylpyrene Inhibitors of Cytochrome P450.

Authors:  Naijue Zhu; Danielle Lightsey; Jiawang Liu; Maryam Foroozesh; Kathleen M Morgan; Edwin D Stevens; Cheryl L Klein Stevens
Journal:  J Chem Crystallogr       Date:  2010-04-01       Impact factor: 0.603

3.  DESIGN, SYNTHESIS, AND EVALUATION OF CARBAZOLE ANALOGS AS POTENTIAL CYTOCHROME P450 INHIBITORS.

Authors:  Maryam Foroozesh; Quan Jiang; Jayalakshmi Sridhar; Jiawang Liu; Brandan Dotson; Erika McClain
Journal:  J Undergrad Chem Res       Date:  2013-09

Review 4.  Acetylenes: cytochrome P450 oxidation and mechanism-based enzyme inactivation.

Authors:  Paul R Ortiz de Montellano
Journal:  Drug Metab Rev       Date:  2019-07-07       Impact factor: 4.518

5.  Inhibition of cytochrome p450 enzymes by quinones and anthraquinones.

Authors:  Jayalakshmi Sridhar; Jiawang Liu; Maryam Foroozesh; Cheryl L Klein Stevens
Journal:  Chem Res Toxicol       Date:  2012-01-10       Impact factor: 3.739

6.  Chemical inactivation of the cinnamate 4-hydroxylase allows for the accumulation of salicylic acid in elicited cells.

Authors:  Guillaume A Schoch; Georgi N Nikov; William L Alworth; Danièle Werck-Reichhart
Journal:  Plant Physiol       Date:  2002-10       Impact factor: 8.340

7.  Inhibition of CYP2B4 by 2-ethynylnaphthalene: evidence for the co-binding of substrate and inhibitor within the active site.

Authors:  Dongmei Cheng; Danni Harris; James R Reed; Wayne L Backes
Journal:  Arch Biochem Biophys       Date:  2007-10-04       Impact factor: 4.013

Review 8.  Computational prediction of metabolism: sites, products, SAR, P450 enzyme dynamics, and mechanisms.

Authors:  Johannes Kirchmair; Mark J Williamson; Jonathan D Tyzack; Lu Tan; Peter J Bond; Andreas Bender; Robert C Glen
Journal:  J Chem Inf Model       Date:  2012-02-17       Impact factor: 4.956

9.  Development of flavone propargyl ethers as potent and selective inhibitors of cytochrome P450 enzymes 1A1 and 1A2.

Authors:  Jayalakshmi Sridhar; Jamie Ellis; Patrick Dupart; Jiawang Liu; Cheryl L Stevens; Maryam Foroozesh
Journal:  Drug Metab Lett       Date:  2012

10.  Differential inhibition of cytochromes P450 3A4 and 3A5 by the newly synthesized coumarin derivatives 7-coumarin propargyl ether and 7-(4-trifluoromethyl)coumarin propargyl ether.

Authors:  Chitra Sridar; Ute M Kent; Kate Noon; Alecia McCall; Bill Alworth; Maryam Foroozesh; Paul F Hollenberg
Journal:  Drug Metab Dispos       Date:  2008-07-24       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.